• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • FREE newsletter subscription
  • Search
  • Menu Menu
International Hospital
  • AI
  • Cardiology
  • Oncology
  • Neurology
  • Genetics
  • Orthopaedics
  • Research
  • Surgery
  • Innovation
  • Medical Imaging
  • MedTech
  • Obs-Gyn
  • Paediatrics

Archive for category: E-News

E-News

reducing unnecessary preoperative testing

Hospital teams reduce unnecessary preoperative testing by tailoring strategies to local workflows

preoperative testing, 9 October 2025/in E-News, Surgery /by panglobal

A tailored, multi-faceted intervention has achieved substantial reductions in wasteful pre-surgery testing across Michigan hospitals, demonstrating that education, teamwork and site-specific adaptation can eliminate low-value care whilst preserving patient safety. The RITE-Size programme reduced unnecessary testing rates from 68% to 40% over six months across three hospital settings.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/10/surgery.jpeg 667 1000 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-10-09 11:13:552025-10-09 11:13:55Hospital teams reduce unnecessary preoperative testing by tailoring strategies to local workflows
Billy Boyle, co-founder and CEO, Owlstone Medical

Owlstone Medical secures $49.1 million ARPA-H award

ARPA-H, Owlstone Medical, 9 October 2025/in E-News, Oncology /by panglobal

Cambridge-based breath diagnostics specialist Owlstone Medical has been awarded up to $49.1 million by ARPA-H to develop at-home multi-cancer early detection tests. The POSEIDON programme aims to detect 30+ solid tumours at Stage I using synthetic biosensors analysed through breath and urine samples, addressing critical gaps in accessible cancer screening.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/10/Owlstone_Boyle.jpg 1000 1000 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-10-09 10:50:062025-10-09 10:50:06Owlstone Medical secures $49.1 million ARPA-H award
World’s first pig-to-human liver xenotransplant© Journal of Hepatology / Zhang et al.

First pig-to-human liver transplant reported

xenotransplantation, 9 October 2025/in E-News, Organ Transplant /by panglobal

A landmark case published in the Journal of Hepatology describes the world’s first auxiliary liver xenotransplant from a genetically engineered pig to a living human recipient, with the patient surviving 171 days. The procedure demonstrates that genetically modified porcine livers can support essential hepatic functions in humans, whilst highlighting significant complications that must be addressed […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/10/liver_xenotransplant.jpg 700 694 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-10-09 06:10:202025-10-08 12:50:25First pig-to-human liver transplant reported
paediatric CNS biorepository established in US partnership

Novel paediatric CNS biorepository established in US partnership

biorepository, COMBINEDBrain, Medical University of South Carolina, 8 October 2025/in E-News, Neurology /by panglobal

COMBINEDBrain and the Medical University of South Carolina have announced a strategic collaboration to establish what they describe as the first biorepository dedicated to paediatric central nervous system tissue and cerebrospinal fluid from neurotypical donors, addressing a significant gap in neurological disease research infrastructure.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/10/CNS.jpg 720 1280 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-10-08 12:38:542025-10-08 12:38:54Novel paediatric CNS biorepository established in US partnership
dendritic nanotubes in the brain

Scientists discover hidden neural network that may drive early Alzheimer’s disease

brain, dendritic nanotubes, 6 October 2025/in E-News, Mental health, Neurology /by panglobal

Researchers have identified dendritic nanotubes – ultrathin connections between neurons that can transport disease-related proteins. The structures, distinct from conventional synapses, may accelerate toxic protein accumulation in specific brain cells during early Alzheimer’s pathology, offering potential new therapeutic targets.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2023/02/shutterstock_1907619667-scaled-e1680868601122.jpg 506 900 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-10-06 10:36:522025-10-06 10:36:52Scientists discover hidden neural network that may drive early Alzheimer’s disease
osteoporosis

Mechanosensitive receptor offers new approach to osteoporosis treatment

osteoporosis, 6 October 2025/in E-News, Orthopaedics, Research /by panglobal

Researchers have identified GPR133/ADGRD1, a mechanosensitive adhesion G protein-coupled receptor, as a promising therapeutic target for osteoporosis. The receptor responds to both mechanical forces and molecular signals, enhancing bone formation through cAMP-dependent activation of β-catenin signalling. A novel small-molecule agonist significantly alleviated osteoporosis in preclinical models, suggesting potential for clinical development.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2021/12/Osteoporosis_22.jpg 471 1000 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-10-06 10:26:512025-10-06 10:26:51Mechanosensitive receptor offers new approach to osteoporosis treatment
patient perspectives

Patients identify six key areas for surgeon communication

communication, 6 October 2025/in E-News, Oncology, Patient Experience, Research /by panglobal

A systematic review of patient perspectives reveals that cancer patients prioritise emotional support, optimistic demeanour, and realistic expectation-setting from their surgical oncologists alongside clinical expertise. The research identifies six distinct communication domains that shape patient satisfaction and treatment adherence.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/10/patient_doctor-communication.jpg 667 1000 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-10-06 07:00:212025-10-03 08:01:06Patients identify six key areas for surgeon communication
Mayo Clinic

Mayo Clinic launches AI-powered clinical development platform leveraging international partner ecosystem

Mayo Clinic, 3 October 2025/in AI, E-News, Research /by panglobal

Mayo Clinic has launched Mayo Clinic Platform_Orchestrate, a comprehensive programme designed to accelerate clinical development by providing biopharma and medical device companies with streamlined access to de-identified clinical data, artificial intelligence tools, and international research networks.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/10/Mayo_Clinic_logo.png 1025 936 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-10-03 07:46:402025-10-03 07:46:40Mayo Clinic launches AI-powered clinical development platform leveraging international partner ecosystem
MEDICAL JAPAN 2025 TOKYO

MEDICAL JAPAN 2025 TOKYO to showcase new pavilions, collaborations, and innovations

, 17 September 2025/in E-News, Events /by panglobal

Healthcare professionals, business leaders, and innovators from across Asia and beyond will converge at Makuhari Messe for MEDICAL JAPAN 2025 TOKYO to experience an immersive exhibition of medical, elderly care, pharmacy, and healthcare, with over 650 exhibitors and an anticipated 18,000 visitors from October 1 to 3, 2025.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/09/image002.jpg 660 991 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-09-17 14:04:402025-09-17 14:04:40MEDICAL JAPAN 2025 TOKYO to showcase new pavilions, collaborations, and innovations
sound waves

New research shows sound waves trigger cellular gene responses and suppress fat development

regenerative medicine, 16 September 2025/in E-News /by panglobal

Researchers in Japan have demonstrated that acoustic waves in the audible frequency range can directly modulate gene expression in mammalian cells and significantly inhibit adipocyte differentiation. The study reveals a novel mechanotransduction pathway linking sound stimulation to cellular responses via focal adhesion signalling, opening potential applications in regenerative medicine and biotechnology.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/09/sounds_waves.jpg 361 842 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-09-16 08:00:232025-09-17 11:55:15New research shows sound waves trigger cellular gene responses and suppress fat development
Page 1 of 236123›»

Latest issue of International Hospital

April 2024

9 October 2025

electronRx launches pDx app for remote lung monitoring

9 October 2025

Hospital teams reduce unnecessary preoperative testing by tailoring strategies to local workflows

9 October 2025

GE HealthCare’s Revolution Vibe CT receives FDA clearance

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign in for our newsletter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Media kit
    • Submit Press Release

Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Sign in for our newsletter

Free subscription